Literature DB >> 20174850

Cardiorenal syndrome: still not a defined entity.

Carlo Longhini1, Christian Molino, Fabio Fabbian.   

Abstract

Because of the increasing incidence of cardiac failure and chronic renal failure due to the progressive aging of the population, the extensive application of cardiac interventional techniques, the rising rates of obesity and diabetes mellitus, coexistence of heart failure and renal failure in the same patient are frequent. More than half of subjects with heart failure had renal impairment, and mortality worsened incrementally across the range of renal dysfunctions. In patients with heart failure, renal dysfunction can result from intrinsic renal disease, hemodynamic abnormalities, or their combination. Severe pump failure leads to low cardiac output and hypotension, and neurohormonal activation produces both fluid retention and vasoconstriction. However, the cardiorenal connection is more elaborate than the hemodynamic model alone; effects of the renin-angiotensin system, the balance between nitric oxide and reactive oxygen species, inflammation, anemia and the sympathetic nervous system should be taken into account. The management of cardiorenal patients requires a tailored therapy that prioritizes the preservation of the equilibrium of each individual patient. Intravascular volume, blood pressure, renal hemodynamic, anemia and intrinsic renal disease management are crucial for improving patients' survival. Complications should be foreseen and prevented, looking carefully at basic physical examination, weight and blood pressure monitoring, and blood, urine urea and electrolytes measurement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20174850     DOI: 10.1007/s10157-009-0257-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  94 in total

1.  Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure.

Authors:  G Marenzi; G Lauri; M Grazi; E Assanelli; J Campodonico; P Agostoni
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

2.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

3.  Erythropoietin triggers a signaling pathway in endothelial cells and increases the thrombogenicity of their extracellular matrices in vitro.

Authors:  Berta Fusté; Mireia Serradell; Ginés Escolar; Aleix Cases; Roberto Mazzara; Ricardo Castillo; Antonio Ordinas; Maribel Díaz-Ricart
Journal:  Thromb Haemost       Date:  2002-10       Impact factor: 5.249

4.  Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

Authors:  George Dangas; Ioannis Iakovou; Eugenia Nikolsky; Eve D Aymong; Gary S Mintz; Nicholas N Kipshidze; Alexandra J Lansky; Issam Moussa; Gregg W Stone; Jeffrey W Moses; Martin B Leon; Roxana Mehran
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

5.  Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.

Authors: 
Journal:  Anesthesiology       Date:  1996-03       Impact factor: 7.892

Review 6.  Ultrafiltration in heart failure.

Authors:  Maya Guglin; Latha Polavaram
Journal:  Cardiol Rev       Date:  2007 Sep-Oct       Impact factor: 2.644

Review 7.  NSAIDs and increased blood pressure. What is the clinical significance?

Authors:  A G Johnson
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

8.  Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

Authors:  G L Bakris; M R Weir; V DeQuattro; F G McMahon
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

9.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

Review 10.  The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome.

Authors:  Donald S Silverberg; Dov Wexler; Miriam Blum; Yoram Wollman; Doron Schwartz; David Sheps; Gad Keren; Adrian Iaina
Journal:  Blood Purif       Date:  2004-05-27       Impact factor: 2.614

View more
  9 in total

Review 1.  Urine biochemistry assessment in critically ill patients: controversies and future perspectives.

Authors:  Alexandre Toledo Maciel; Daniel Vitorio
Journal:  J Clin Monit Comput       Date:  2016-04-01       Impact factor: 2.502

Review 2.  Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.

Authors:  Paolo C Colombo; Anjali Ganda; Jeffrey Lin; Duygu Onat; Ante Harxhi; Julia E Iyasere; Nir Uriel; Gad Cotter
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 3.  Pathogenesis and therapeutic implications of cardiorenal syndrome.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2010-11-23       Impact factor: 2.801

4.  Seasonal pattern in elderly hospitalized with acute kidney injury: a retrospective nationwide study in Italy.

Authors:  Alfredo De Giorgi; Alda Storari; Pedro Manuel Rodríguez-Muñoz; Rosaria Cappadona; Nicola Lamberti; Fabio Manfredini; Pablo Jesús López-Soto; Roberto Manfredini; Fabio Fabbian
Journal:  Int Urol Nephrol       Date:  2022-07-02       Impact factor: 2.370

5.  Tissue Doppler-derived E/e' ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease.

Authors:  Min Keun Kim; Biro Kim; Jun Young Lee; Jae Seok Kim; Byoung-Geun Han; Seung Ok Choi; Jae Won Yang
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

6.  Decreased vancomycin clearance in patients with congestive heart failure.

Authors:  Yuko Shimamoto; Tsuyoshi Fukuda; Shinjiro Tominari; Kyoko Fukumoto; Kazuyuki Ueno; Min Dong; Kazuhiko Tanaka; Takuma Shirasaka; Katsuya Komori
Journal:  Eur J Clin Pharmacol       Date:  2012-07-12       Impact factor: 2.953

7.  Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward.

Authors:  F Fabbian; M Pala; A De Giorgi; A Scalone; C Molino; F Portaluppi; D P Mikhailidis; R Manfredini
Journal:  Open Cardiovasc Med J       Date:  2011-11-18

Review 8.  The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation.

Authors:  John G Kingma; Denys Simard; Jacques R Rouleau; Benoit Drolet; Chantale Simard
Journal:  J Cardiovasc Dev Dis       Date:  2017-11-29

9.  Olmesartan medoxomil reverses glomerulosclerosis in renal tissue induced by myocardial infarction without changes in renal function.

Authors:  Xiao-Mei Lu; Yu-Nan Jin; Ling Ma
Journal:  Exp Ther Med       Date:  2014-04-25       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.